European Molecular Biology Laboratory

The European Molecular Biology Laboratory (EMBL) is Europe's esteemed lab network for research in molecular biology. EMBL is funded by 20 member states an one associate member. EMBL operates in 5 sites, the main laboratory is in Heidelberg, Germany. Additionally, EMBL manages the European Bioinformatics Institute in Hinxton, Grenoble, Hamburg and Monterotondo near Rome, Italy. Research at EMBL covers the entire spectrum of research in molecular biology. The mission of EMBL is to train scientists at all levels, perform basic molecular biology research and to create new instruments and methods in the broad field of life science and technology development. EMBL has a PhD program and currently has 170 candidates in the program. EMBL publishes updates news about their current research and welcomes the public and media to visit or connect with them about their work.

Address
EMBL Heidelberg Meyerhofstra?e 1 Heidelberg D-69117 Germany
Website
http://emblorg.embl.de/
Wikipedia
http://en.wikipedia.org/wiki/European_Molecular_Biology_Laboratory

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Oncology & Cancer

Global microbial signatures for colorectal cancer established

Cancers have long been known to arise due to environmental exposures such as unhealthy diet or smoking. Lately, the microbes living in and on our body have entered the stage as key players: while stomach cancer can be caused ...

Medical research

Using light to stop itch

Itch is easily one of the most annoying sensations. For chronic skin diseases like eczema, it's a major symptom. Although it gives temporary relief, scratching only makes things worse because it can cause skin damage, additional ...

Diseases, Conditions, Syndromes

Flu's response to new drug explored

The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018. Scientists from EMBL Grenoble have now investigated the drug's mode of action ...

Oncology & Cancer

Miniature testing of drug pairs on tumour biopsies

Combinations of cancer drugs can be quickly and cheaply tested on tumour cells using a novel device developed by EMBL scientists. The research, reported in Nature Communications on June 22, marks the latest advancement in ...

Medical research

Towards personalised medicine: One type of data is not enough

EMBL researchers have designed a computational method to jointly analyse multiple types of molecular data from patients in order to identify molecular signatures that distinguish individuals. The method is called Multi-Omics ...

Oncology & Cancer

New insights into the origins of mutations in cancer

Researchers at the European Bioinformatics Institute (EMBL-EBI), the University of Dundee and the Wellcome Sanger Institute have used human and worm data to explore the mutational causes of cancer. Their study, published ...

Oncology & Cancer

PDX finder—Free global portal for cancer models

The European Bioinformatics Institute (EMBL-EBI) and The Jackson Laboratory (JAX) have jointly developed the first open cancer research portal for Patient Derived Xenograft (PDX) models. The freely available PDX Finder is ...

Medical research

Commonly used drugs affect gut bacteria

One in four drugs with human targets inhibit the growth of bacteria in the human gut. These drugs cause antibiotic-like side-effects and may promote antibiotic resistance, EMBL researchers report in Nature on March 19.

page 1 from 6